In a surprising revelation, NFL legend Tom Brady claims his beloved dog, Junie, is a clone of his previous pet, Lua, who passed away in 2023. But this isn't just any cloning story—it's intertwined with a groundbreaking biotech venture.
The iconic quarterback and Fox Sports broadcaster made this announcement on November 4, 2025, in a statement released by Colossal Biosciences, a company he has invested in. Colossal, valued at a staggering $10 billion, aims to tackle extinction and has just acquired another cloning firm, Viagen Pets and Equine.
Brady's involvement with Colossal began a few years ago when he utilized their cutting-edge cloning technology to preserve the genetics of his family's elderly dog, Lua. But here's where it gets controversial: the cloning process was initiated before Lua's passing, sparking ethical questions about the timing of such procedures.
Junie, a pit bull mix, is the result of this cloning endeavor. Brady and his former wife, supermodel Giselle Bundchen, adopted Lua before their divorce in 2022. Colossal's cloning and genetic engineering expertise also led to the birth of three dire wolf pups in 2024, a species previously believed to be extinct. However, this claim was disputed by conservation groups, leaving the scientific community divided.
This story raises intriguing questions about the ethics and potential of cloning. Is it a way to preserve beloved pets and even revive extinct species, or does it cross ethical boundaries? What do you think about the timing of cloning procedures and the implications for conservation efforts? Share your thoughts and let's explore the fascinating world of biotechnology together!
